It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The impact of viral keratitis (VK) on individuals and society is notable. Early diagnosis and treatment are crucial in managing viral keratitis effectively. Timely intervention with antiviral medications and supportive care can help mitigate the severity of the infection and improve visual outcomes. We examined the prevalence of varicella-zoster virus (VZV), herpes simplex virus type 1 (HSV-1), adenovirus (AdV) and herpes simplex virus type 2 (HSV-2) in patients suspected for ocular infections. Patients included in the study exhibited various clinical manifestations indicative of ocular pathology, such as infectious keratitis, corneal scar, endogenous endophthalmitis, panuveitis, endothelitis, stromal edema, and other relevant conditions. Four different types of tear fluid, corneal samples epithelium, aqueous humor and vitreous humor were taken. After genome extraction, multiplex real-time PCR was used for diagnosis of viruses. 48 (29.6%) out of the total of 162 (100%) eye specimen were positive. The dominant prevalence was VZV (12.3%) and HSV-1 (11.7%) followed by AdV (4.9%) and HSV-2 (0.6%). There were 4 (8.3%) coinfections within the samples (HSV-1 and VZV). Aqueous humor samples demonstrated superior virus detection ability and our only HSV-2 positive sample was from aqueous humor. The utilization of multiplex real-time PCR assays in differential diagnosis of VK holds promise for expeditious diagnoses while also preventing unwarranted antibiotic prescriptions. Moreover, the aqueous humor appears to be a more sensitive site for detecting viral keratitis.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Tehran University of Medical Sciences, Department of Virology, School of Public Health, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922); Tehran University of Medical Science, Research Center for Clinical Virology, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)
2 Iran University of Medical Sciences, Department of Immunology, School of Medicine, Tehran, Iran (GRID:grid.411746.1) (ISNI:0000 0004 4911 7066)
3 Tehran University of Medical Sciences, Department of Virology, School of Public Health, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)
4 Tehran University of Medical Science, Research Center for Clinical Virology, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922); Tehran University of Medical Sciences, Epidemiology and statistics Department, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)
5 Tehran University of Medical Science, Research Center for Clinical Virology, Tehran, Iran (GRID:grid.411705.6) (ISNI:0000 0001 0166 0922)